Triggering receptor on myeloid cells 2 (TREM2) is an innate immune receptor, upregulated on the surface of microglia associated with amyloid plaques in Alzheimer's disease (AD). This evidence concerns the gene TREM2 and early-onset autosomal dominant Alzheimer disease.